Recent studies demonstrated that SLC1A5, the primary glutamine transporter, could promote tumor cell growth, cell cycle progression and survival in neuroblastoma, colorectal cancer, breast cancer and prostate cancer19, 20, 21, 22. The gene discussed is SLC1A5; the disease is neoplasm.